Roundtable Discussion: What Can We Learn from Depletion of Tregs in Cancer to Enhance Treg Expansion in Autoimmune Disease, Allergy & Transplantation?
Time: 3:30 pm
day: Day Two
- Discussing drug design approaches used to elicit antitumor immunity to advance specific targeting of Tregs
- Utilizing next generation platforms and transcriptomic screening methods to identify Treg targets in oncology to avoid in autoimmunity
- Discussing learnings from clinical and nonclinical data of Treg targeting in solid tumors for a better understanding of how to selectively target Tregs in autoimmune conditions
- Discussing interactions between Tregs and MDSC in the TME that may be applicable to expanding Tregs in autoimmunity